{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:18:38Z","timestamp":1788002318345,"version":"build-2784847793"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270626"],"award-info":[{"award-number":["82270626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jhep.2026.04.019","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:44:07Z","timestamp":1777495447000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond steroid-dependent care: Can TNF blockade evolve into a precision therapy for autoimmune hepatitis?"],"prefix":"10.1016","author":[{"given":"Xinghuan","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-7536","authenticated-orcid":false,"given":"Guiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.04.019_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jhep.2026.02.026","article-title":"Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis","volume":"85","author":"Xu","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.019_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(25)00938-9","article-title":"FRI-309 Single-cell profiles of intrahepatic and peripheral immune cells reveal AIH-specific CD8+ T cells promote disease progression through cytotoxicity and macrophage interactions","volume":"82","author":"Fu","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.019_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2024.12.041","article-title":"Update in clinical science: autoimmune hepatitis","volume":"82","author":"Heneghan","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.04.019_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41467-025-56363-2","article-title":"Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting","volume":"16","author":"Cardon","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.019_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404309121","article-title":"Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues","volume":"121","author":"Eslami","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2026.04.019_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/gutjnl-2021-325915","article-title":"Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients","volume":"72","author":"Zhang","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.04.019_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/annrheumdis-2019-216068","article-title":"Contrasting contributions of TNF from distinct cellular sources in arthritis","volume":"79","author":"Kruglov","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2026.04.019_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70195","article-title":"Risk of serious infections in patients treated with biologic or targeted-synthetic disease modifying antirheumatic drugs in Qatar","volume":"13","author":"Sasi","year":"2025","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jhep.2026.04.019_bib9","article-title":"Beneath the surface: exploring hidden threats of long-term corticosteroid therapy to bone density","volume":"16","author":"Alfaedi","year":"2024","journal-title":"Cureus"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:06:08Z","timestamp":1788001568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826002229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":9,"alternative-id":["S0168827826002229"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond steroid-dependent care: Can TNF blockade evolve into a precision therapy for autoimmune hepatitis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.02.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}